GREY:CWBR - Post Discussion
CohBar Inc
> CohBar Engages LifeSci Advisors as Investor Relations
Post by
GreenDream on Sep 27, 2018 2:02pm
CohBar Engages LifeSci Advisors as Investor Relations
MENLO PARK, Calif., Sept. 25, 2018 (GLOBE NEWSWIRE) -- CohBar, Inc. (NASDAQ: CWBR), a clinical stage biotechnology company developing mitochondria based therapeutics (MBTs) to treat age-related diseases, today announced that it has engaged LifeSci Advisors LLC ("LifeSci"), a leading New York-based investor relations consultancy serving life science companies, to implement a comprehensive investor outreach program that will include analyst and investor targeting/outreach, non-deal roadshows, corporate communications, and Key Opinion Leader (KOL) events in the field of mitochondria based therapeutics and age-related diseases.
“The decision to engage LifeSci Advisors advances our strategic initiative to expand awareness of CohBar in the investment community, particularly among institutional investors,” said Simon Allen, Chief Executive Officer of CohBar. “The team at LifeSci, with its extensive Wall Street experience, brings a unique set of capabilities that will enable us to present our compelling story to a wide audience of sophisticated prospective investors, both in the U.S. and internationally.”GLOBENEWSWIRE
Be the first to comment on this post